Report Description Table Of Content Research Methodology Download Free Sample

Market Snapshot

CAGR:9.34

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	9.34

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

The Human Microbiome Market size is estimated to grow at a CAGR of 6.78% between 2022 and 2032. The market size is forecast to increase by USD 12,345.67 million. The growth of the market depends on several factors, including the increasing awareness about the role of the human microbiome in maintaining health, advancements in metagenomics and next-generation sequencing technologies, and the rising prevalence of chronic diseases. The human microbiome refers to the collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in and on the human body. These microorganisms play a crucial role in various physiological processes, such as digestion, immune system regulation, and metabolism. The study of the human microbiome has gained significant attention in recent years due to its potential implications for understanding and treating various diseases.

Human Microbiome Market Overview

Drivers

One of the key factors driving the human microbiome market growth is the increasing awareness about the role of the human microbiome in maintaining health. Research studies have highlighted the importance of a balanced and diverse microbiome in promoting overall health and preventing various diseases. This has led to a growing interest among healthcare professionals and consumers in understanding and modulating the human microbiome to improve health outcomes. Additionally, advancements in metagenomics and next-generation sequencing technologies have enabled researchers to study the human microbiome in greater detail, further fueling the market growth.

Moreover, the rising prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disease, has been linked to alterations in the human microbiome. This has led to increased research efforts to identify the specific microbial imbalances associated with these diseases and develop targeted interventions. As a result, there is a growing demand for microbiome-based diagnostics, therapeutics, and personalized medicine approaches. Hence, such factors are expected to drive market growth during the forecast period.

Trends

A key trend shaping the human microbiome market growth is the development of microbiome-based therapeutics. Researchers and pharmaceutical companies are exploring the potential of using specific microbial strains or their metabolites to develop novel therapeutics for various diseases. For example, fecal microbiota transplantation (FMT) has emerged as an effective treatment for recurrent Clostridium difficile infection, where the healthy microbiota from a donor is transplanted into the patient's gut to restore microbial balance. Additionally, there is growing interest in developing microbiome-based therapies for conditions such as inflammatory bowel disease, metabolic disorders, and even mental health disorders.

Furthermore, the concept of personalized medicine is gaining traction in the field of human microbiome research. The idea is to tailor interventions based on an individual's unique microbiome composition and characteristics. This involves analyzing an individual's microbiome profile and identifying specific microbial imbalances or dysbiosis that may contribute to disease development or progression. Personalized interventions can then be designed to restore microbial balance and improve health outcomes. Hence, such trends are expected to drive market growth during the forecast period.

Restraints:

One of the key challenges hindering the human microbiome market growth is the complexity of the human microbiome and its interactions with the host. The human microbiome is highly diverse and dynamic, varying between individuals and even within the same individual over time. This complexity makes it challenging to identify specific microbial signatures or establish causal relationships between microbial imbalances and disease outcomes. Additionally, the interactions between the microbiome and the host are multifaceted and influenced by various factors, including genetics, diet, lifestyle, and environmental exposures. Understanding these complex interactions and their implications for health requires extensive research and data analysis, which can be time-consuming and resource-intensive.

Furthermore, regulatory considerations pose another challenge for the development and commercialization of microbiome-based products. The regulatory landscape for microbiome-based therapeutics and diagnostics is still evolving, and there is a need for clear guidelines and standards to ensure safety and efficacy. The lack of standardized protocols and validated biomarkers also hinders the translation of microbiome research into clinical practice. Hence, such factors are expected to hinder market growth during the forecast period.

Human Microbiome Market Segmentation By Application

The gastrointestinal disorders segment is estimated to witness significant growth during the forecast period. The human gut microbiome plays a crucial role in maintaining gut health and has been implicated in the pathogenesis of various gastrointestinal disorders, such as inflammatory bowel disease, irritable bowel syndrome, and colorectal cancer. Research studies have identified specific microbial imbalances or dysbiosis associated with these conditions, opening up opportunities for developing microbiome-based diagnostics and therapeutics. For example, microbiome profiling can help identify microbial biomarkers for early detection and risk stratification of colorectal cancer. Additionally, interventions targeting the gut microbiome, such as probiotics, prebiotics, and FMT, have shown promise in managing gastrointestinal disorders. Hence, such applications are expected to fuel the growth of this segment, driving the market growth during the forecast period.

Human Microbiome Market Segmentation By Type

The bacterial segment is expected to dominate the human microbiome market during the forecast period. Bacteria are the most abundant and well-studied microorganisms in the human microbiome. They play a crucial role in various physiological processes, including digestion, immune system regulation, and metabolism. Alterations in the composition and diversity of bacterial communities have been associated with various diseases, making bacteria a key focus of microbiome research. Advances in metagenomics and next-generation sequencing technologies have enabled researchers to characterize bacterial communities in greater detail, facilitating the identification of specific bacterial taxa or functional genes associated with health or disease. Hence, such factors are expected to drive the demand for bacterial microbiome analysis and therapeutics, contributing to the market growth during the forecast period.

Regional Overview

North America is estimated to contribute the largest share to the growth of the global human microbiome market during the forecast period. The region has a well-established healthcare infrastructure, a strong presence of key market players, and a high level of research and development activities in the field of microbiome research. The United States, in particular, is a major hub for microbiome research, with several academic institutions, research organizations, and biotechnology companies actively engaged in studying the human microbiome and developing microbiome-based products. Additionally, the high prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disease, in North America has fueled the demand for microbiome-based diagnostics and therapeutics. Hence, such factors are expected to drive market growth in the region during the forecast period.

In 2020, during the COVID-19 pandemic, the growth of the global human microbiome market witnessed a temporary slowdown due to disruptions in research activities and healthcare services. However, with the gradual resumption of research and clinical activities, the market is expected to recover and witness steady growth in the coming years. The ongoing research on the role of the human microbiome in immune system regulation and infectious diseases, including COVID-19, is expected to further drive the market during the forecast period.

Human Microbiome Market Customer Landscape

The human microbiome market industry report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Who are the Major Human Microbiome Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Some of the major companies operating in the human microbiome market include:

4D Pharma PLC
Enterome SA
Ferring Pharmaceuticals Inc.
Merck & Co., Inc.
Rebiotix Inc.
Seres Therapeutics Inc.
Vedanta Biosciences Inc.
Viome Inc.
Vedanta Biosciences Inc.
Zymo Research Corp.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

BioGaia AB
Evelo Biosciences Inc.
Ginkgo Bioworks Inc.
Microbiome Therapeutics LLC
Second Genome Inc.
Synlogic Inc.
Ubiome Inc.
Vedanta Biosciences Inc.
Viome Inc.
Vithera Pharmaceuticals Inc.

The human microbiome market report provides a qualitative and quantitative analysis of the healthcare industry, helping clients understand the broader business environment and the strengths and weaknesses of key market players. The data is analyzed qualitatively to categorize companies based on their focus, such as pure play, category-focused, industry-focused

The human microbiome market report forecasts market growth by revenue at the global, regional, and country levels, offering an analysis of the latest trends and growth opportunities from 2019 to 2032.

Application Outlook (USD Million, 2019 - 2032)

Gastrointestinal Disorders

Infectious Diseases

Metabolic Disorders

Immune System Disorders

Dermatological Disorders

Others

Type Outlook (USD Million, 2019 - 2032)

Probiotics

Prebiotics

Medical Foods

Diagnostic Tests

Drugs

Others

Geography Outlook (USD Million, 2019 - 2032)

North America

United States

Canada

Europe

United Kingdom

Germany

France

Rest of Europe

Asia-Pacific

China

India

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

South Africa

Rest of Middle East & Africa

Global Human Microbiome Market Research Report 2017

1 Human Microbiome Market Overview

1.1 Product Overview and Scope of Human Microbiome

1.2 Human Microbiome Segment by Type (Product Category)

1.2.1 Global Human Microbiome Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)

1.2.2 Global Human Microbiome Production Market Share by Type (Product Category) in 2016

1.2.3 Prebiotics

1.2.4 Medical Foods

1.2.5 Drugs

1.2.6 Probiotics

1.2.7 Food

1.2.8 Devices

1.2.9 Other Probiotic Supplements

1.3 Global Human Microbiome Segment by Application

1.3.1 Human Microbiome Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Diagnostics

1.3.3 Therapeutics

1.4 Global Human Microbiome Market by Region (2012-2022)

1.4.1 Global Human Microbiome Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Human Microbiome (2012-2022)

1.5.1 Global Human Microbiome Revenue Status and Outlook (2012-2022)

1.5.2 Global Human Microbiome Capacity, Production Status and Outlook (2012-2022)

2 Global Human Microbiome Market Competition by Manufacturers

2.1 Global Human Microbiome Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Human Microbiome Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Human Microbiome Production and Share by Manufacturers (2012-2017)

2.2 Global Human Microbiome Revenue and Share by Manufacturers (2012-2017)

2.3 Global Human Microbiome Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Human Microbiome Manufacturing Base Distribution, Sales Area and Product Type

2.5 Human Microbiome Market Competitive Situation and Trends

2.5.1 Human Microbiome Market Concentration Rate

2.5.2 Human Microbiome Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Microbiome Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Human Microbiome Capacity and Market Share by Region (2012-2017)

3.2 Global Human Microbiome Production and Market Share by Region (2012-2017)

3.3 Global Human Microbiome Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Human Microbiome Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Human Microbiome Consumption by Region (2012-2017)

4.2 North America Human Microbiome Production, Consumption, Export, Import (2012-2017)

4.3 Europe Human Microbiome Production, Consumption, Export, Import (2012-2017)

4.4 China Human Microbiome Production, Consumption, Export, Import (2012-2017)

4.5 Japan Human Microbiome Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Human Microbiome Production, Consumption, Export, Import (2012-2017)

4.7 India Human Microbiome Production, Consumption, Export, Import (2012-2017)

5 Global Human Microbiome Production, Revenue (Value), Price Trend by Type

5.1 Global Human Microbiome Production and Market Share by Type (2012-2017)

5.2 Global Human Microbiome Revenue and Market Share by Type (2012-2017)

5.3 Global Human Microbiome Price by Type (2012-2017)

5.4 Global Human Microbiome Production Growth by Type (2012-2017)

6 Global Human Microbiome Market Analysis by Application

6.1 Global Human Microbiome Consumption and Market Share by Application (2012-2017)

6.2 Global Human Microbiome Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Human Microbiome Manufacturers Profiles/Analysis

7.1 Merck

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Human Microbiome Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Merck Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 DuPont

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Human Microbiome Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 DuPont Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 MicroBiome Therapeutics

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Human Microbiome Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 MicroBiome Therapeutics Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Osel

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Human Microbiome Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Osel Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Metabiomics Corporation

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Human Microbiome Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Metabiomics Corporation Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Enterome Bioscience

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Human Microbiome Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Enterome Bioscience Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Yakult

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Human Microbiome Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Yakult Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 ViThera Pharmaceuticals

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Human Microbiome Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 ViThera Pharmaceuticals Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Vedanta BioSciences

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Human Microbiome Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Vedanta BioSciences Human Microbiome Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

8 Human Microbiome Manufacturing Cost Analysis

8.1 Human Microbiome Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Human Microbiome

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Human Microbiome Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Human Microbiome Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Human Microbiome Market Forecast (2017-2022)

12.1 Global Human Microbiome Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Human Microbiome Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Human Microbiome Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Human Microbiome Price and Trend Forecast (2017-2022)

12.2 Global Human Microbiome Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Human Microbiome Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Human Microbiome Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Human Microbiome Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

Figure Picture of Human Microbiome

Figure Global Human Microbiome Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global Human Microbiome Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Prebiotics

Table Major Manufacturers of Prebiotics

Figure Product Picture of Medical Foods

Table Major Manufacturers of Medical Foods

Figure Product Picture of Drugs

Table Major Manufacturers of Drugs

Figure Product Picture of Probiotics

Table Major Manufacturers of Probiotics

Figure Product Picture of Food

Table Major Manufacturers of Food

Figure Product Picture of Devices

Table Major Manufacturers of Devices

Figure Product Picture of Other Probiotic Supplements

Table Major Manufacturers of Other Probiotic Supplements

Figure Global Human Microbiome Consumption (K Units) by Applications (2012-2022)

Figure Global Human Microbiome Consumption Market Share by Applications in 2016

Figure Diagnostics Examples

Figure Therapeutics Examples

Figure Global Human Microbiome Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)

Figure North America Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Human Microbiome Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global Human Microbiome Capacity, Production (K Units) Status and Outlook (2012-2022)

Figure Global Human Microbiome Major Players Product Capacity (K Units) (2012-2017)

Table Global Human Microbiome Capacity (K Units) of Key Manufacturers (2012-2017)

Table Global Human Microbiome Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global Human Microbiome Capacity (K Units) of Key Manufacturers in 2016

Figure Global Human Microbiome Capacity (K Units) of Key Manufacturers in 2017

Figure Global Human Microbiome Major Players Product Production (K Units) (2012-2017)

Table Global Human Microbiome Production (K Units) of Key Manufacturers (2012-2017)

Table Global Human Microbiome Production Share by Manufacturers (2012-2017)

Figure 2016 Human Microbiome Production Share by Manufacturers

Figure 2017 Human Microbiome Production Share by Manufacturers

Figure Global Human Microbiome Major Players Product Revenue (Million USD) (2012-2017)

Table Global Human Microbiome Revenue (Million USD) by Manufacturers (2012-2017)

Table Global Human Microbiome Revenue Share by Manufacturers (2012-2017)

Table 2016 Global Human Microbiome Revenue Share by Manufacturers

Table 2017 Global Human Microbiome Revenue Share by Manufacturers

Table Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers (2012-2017)

Figure Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers in 2016

Table Manufacturers Human Microbiome Manufacturing Base Distribution and Sales Area

Table Manufacturers Human Microbiome Product Category

Figure Human Microbiome Market Share of Top 3 Manufacturers

Figure Human Microbiome Market Share of Top 5 Manufacturers

Table Global Human Microbiome Capacity (K Units) by Region (2012-2017)

Figure Global Human Microbiome Capacity Market Share by Region (2012-2017)

Figure Global Human Microbiome Capacity Market Share by Region (2012-2017)

Figure 2016 Global Human Microbiome Capacity Market Share by Region

Table Global Human Microbiome Production by Region (2012-2017)

Figure Global Human Microbiome Production (K Units) by Region (2012-2017)

Figure Global Human Microbiome Production Market Share by Region (2012-2017)

Figure 2016 Global Human Microbiome Production Market Share by Region

Table Global Human Microbiome Revenue (Million USD) by Region (2012-2017)

Table Global Human Microbiome Revenue Market Share by Region (2012-2017)

Figure Global Human Microbiome Revenue Market Share by Region (2012-2017)

Table 2016 Global Human Microbiome Revenue Market Share by Region

Figure Global Human Microbiome Capacity, Production (K Units) and Growth Rate (2012-2017)

Table Global Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table North America Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Europe Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table China Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Japan Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Southeast Asia Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table India Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Global Human Microbiome Consumption (K Units) Market by Region (2012-2017)

Table Global Human Microbiome Consumption Market Share by Region (2012-2017)

Figure Global Human Microbiome Consumption Market Share by Region (2012-2017)

Figure 2016 Global Human Microbiome Consumption (K Units) Market Share by Region

Table North America Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table Europe Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table China Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table Japan Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table Southeast Asia Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table India Human Microbiome Production, Consumption, Import & Export (K Units) (2012-2017)

Table Global Human Microbiome Production (K Units) by Type (2012-2017)

Table Global Human Microbiome Production Share by Type (2012-2017)

Figure Production Market Share of Human Microbiome by Type (2012-2017)

Figure 2016 Production Market Share of Human Microbiome by Type

Table Global Human Microbiome Revenue (Million USD) by Type (2012-2017)

Table Global Human Microbiome Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Human Microbiome by Type (2012-2017)

Figure 2016 Revenue Market Share of Human Microbiome by Type

Table Global Human Microbiome Price (USD/Unit) by Type (2012-2017)

Figure Global Human Microbiome Production Growth by Type (2012-2017)

Table Global Human Microbiome Consumption (K Units) by Application (2012-2017)

Table Global Human Microbiome Consumption Market Share by Application (2012-2017)

Figure Global Human Microbiome Consumption Market Share by Applications (2012-2017)

Figure Global Human Microbiome Consumption Market Share by Application in 2016

Table Global Human Microbiome Consumption Growth Rate by Application (2012-2017)

Figure Global Human Microbiome Consumption Growth Rate by Application (2012-2017)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck Human Microbiome Production Growth Rate (2012-2017)

Figure Merck Human Microbiome Production Market Share (2012-2017)

Figure Merck Human Microbiome Revenue Market Share (2012-2017)

Table DuPont Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table DuPont Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure DuPont Human Microbiome Production Growth Rate (2012-2017)

Figure DuPont Human Microbiome Production Market Share (2012-2017)

Figure DuPont Human Microbiome Revenue Market Share (2012-2017)

Table MicroBiome Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table MicroBiome Therapeutics Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure MicroBiome Therapeutics Human Microbiome Production Growth Rate (2012-2017)

Figure MicroBiome Therapeutics Human Microbiome Production Market Share (2012-2017)

Figure MicroBiome Therapeutics Human Microbiome Revenue Market Share (2012-2017)

Table Osel Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Osel Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Osel Human Microbiome Production Growth Rate (2012-2017)

Figure Osel Human Microbiome Production Market Share (2012-2017)

Figure Osel Human Microbiome Revenue Market Share (2012-2017)

Table Metabiomics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Metabiomics Corporation Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Metabiomics Corporation Human Microbiome Production Growth Rate (2012-2017)

Figure Metabiomics Corporation Human Microbiome Production Market Share (2012-2017)

Figure Metabiomics Corporation Human Microbiome Revenue Market Share (2012-2017)

Table Enterome Bioscience Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Enterome Bioscience Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Enterome Bioscience Human Microbiome Production Growth Rate (2012-2017)

Figure Enterome Bioscience Human Microbiome Production Market Share (2012-2017)

Figure Enterome Bioscience Human Microbiome Revenue Market Share (2012-2017)

Table Yakult Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Yakult Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Yakult Human Microbiome Production Growth Rate (2012-2017)

Figure Yakult Human Microbiome Production Market Share (2012-2017)

Figure Yakult Human Microbiome Revenue Market Share (2012-2017)

Table ViThera Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ViThera Pharmaceuticals Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure ViThera Pharmaceuticals Human Microbiome Production Growth Rate (2012-2017)

Figure ViThera Pharmaceuticals Human Microbiome Production Market Share (2012-2017)

Figure ViThera Pharmaceuticals Human Microbiome Revenue Market Share (2012-2017)

Table Vedanta BioSciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Vedanta BioSciences Human Microbiome Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Vedanta BioSciences Human Microbiome Production Growth Rate (2012-2017)

Figure Vedanta BioSciences Human Microbiome Production Market Share (2012-2017)

Figure Vedanta BioSciences Human Microbiome Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Human Microbiome

Figure Manufacturing Process Analysis of Human Microbiome

Figure Human Microbiome Industrial Chain Analysis

Table Raw Materials Sources of Human Microbiome Major Manufacturers in 2016

Table Major Buyers of Human Microbiome

Table Distributors/Traders List

Figure Global Human Microbiome Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Global Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Human Microbiome Price (Million USD) and Trend Forecast (2017-2022)

Table Global Human Microbiome Production (K Units) Forecast by Region (2017-2022)

Figure Global Human Microbiome Production Market Share Forecast by Region (2017-2022)

Table Global Human Microbiome Consumption (K Units) Forecast by Region (2017-2022)

Figure Global Human Microbiome Consumption Market Share Forecast by Region (2017-2022)

Figure North America Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure North America Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Europe Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Europe Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure China Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure China Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Japan Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Japan Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Southeast Asia Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure India Human Microbiome Production (K Units) and Growth Rate Forecast (2017-2022)

Figure India Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India Human Microbiome Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Table Global Human Microbiome Production (K Units) Forecast by Type (2017-2022)

Figure Global Human Microbiome Production (K Units) Forecast by Type (2017-2022)

Table Global Human Microbiome Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Human Microbiome Revenue Market Share Forecast by Type (2017-2022)

Table Global Human Microbiome Price Forecast by Type (2017-2022)

Table Global Human Microbiome Consumption (K Units) Forecast by Application (2017-2022)

Figure Global Human Microbiome Consumption (K Units) Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Human Microbiome Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032